Refine your search

Content type
Tags
Author
Jurisdiction
Language

3,932 results found

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP logo
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the largest IP law firms in the world. From offices in Atlanta, Boston, London, Palo…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 23 Jun 2022

A Brief Summary of Patent Proceedings Involving Cannabis Patents

To date, there have been relatively few patent proceedings relating to cannabis patents and no court has issued a finding of infringement. With the…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 22 Jun 2022

Fintiv Refined: USPTO Provides Interim Procedure for Discretionary Denials

On June 22, 2022, the USPTO issued guidance on an Interim Procedure for Discretionary Denials (“Guidance”). In the Guidance, Director Vidal notes…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | Global, USA | 22 Jun 2022

Prosecution Pointer 334

With the adoption of ST.26 as the new standard for sequence listings, the USPTO has revised its regulations. On May 20, 2022, the USPTO published a…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 22 Jun 2022

D. Mass. Patent Litigation Update: May 2022

In Banhazl v. The American Ceramic Society, et al., No. 1:16-cv-10791, following a bench trial Judge Burroughs awarded plaintiff Terrie Banhazl $161…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 17 Jun 2022

Podcast Series: Last Month at the Federal Circuit - June 2022

Welcome to the Last Month at the Federal Circuit—a look at recent Federal Circuit decisions impacting the intellectual property community. In this…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 17 Jun 2022

PTAB Reform Act: Senators Introduce PTAB Bill That Would Alter Institution Discretion, Address Arthrex Issues, and Expand Appeal Standing

On June 16, Senators Tillis, Leahy, and Cornyn introduced the “Patent Trial and Appeal Board Reform Act of 2022.” If passed, the bill would modify…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 16 Jun 2022

Medical Device Licensing Pitfalls to Avoid

Licensing and other technology transfer agreements can be critical for medical device companies that invest significantly into new technology R&D and…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 16 Jun 2022

Smart Baby Monitors May Be Considered Medical Devices by FDA

In 2018, Apple made headlines when it released a new version of its smartwatch that included an FDA-cleared electrocardiogram feature. Conor Hale…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 15 Jun 2022

How ITC Is Addressing Its Importation Requirement

A distinguishing aspect of a U.S. International Trade Commission investigation under Section 337 from a district court action is the importation…
Article
Ask Lexy

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | Global, USA | 15 Jun 2022

Prosecution Pointer 333

REMINDER: PCT-SAFE will no longer be supported by WIPO as of July 1, 2022. As such, one can no longer use PCT-SAFE to prep your RO-101 for submission…
Previous page 1 2 3 ...